Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: A randomized, double-blind, 3-week trial

Clinical Therapeutics

Volumn 33, Issue 11, 2011, Pages 1643-1658

  Cutler, Andrew J ^a   Datto, Catherine ^b   Nordenhem, Arvid ^c   Minkwitz, Margaret ^b   Acevedo, Larisa ^b   Darko, Denis ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Bipolar; Extended release; Mania; Once daily; Quetiapine

Indexed keywords

QUETIAPINE;

ABNORMAL DREAMING; ADULT; AGED; AGITATION; ARTICLE; BACKACHE; BIPOLAR I DISORDER; BLURRED VISION; CONSTIPATION; DECREASED APPETITE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSARTHRIA; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; INCREASED APPETITE; INSOMNIA; LETHARGY; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; NAUSEA; NOSE CONGESTION; ORTHOSTATIC HYPERTENSION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SORE THROAT; STOMACH DISCOMFORT; TACHYCARDIA; TOOTH PAIN; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VITAL SIGN; VOMITING; WEIGHT GAIN; XEROSTOMIA; YOUNG MANIA RATING SCALE;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DELAYED-ACTION PREPARATIONS; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 82855161017     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.10.002     Document Type: Article

References (45)

1. Hirschfeld R.M., Calabrese J.R., Weissman M.M., et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003, 64:53-59.
2. Merikangas K.R., Akiskal H.S., Angst J., et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007, 64:543-552.
3. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) 2000, American Psychiatric Association, American Psychiatric Association, Washington, DC.
4. Judd L.L., Akiskal H.S. Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder. Curr Psychiatry Rep 2003, 5:417-418.
5. Kupka R.W., Luckenbaugh D.A., Post R.M., et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005, 162:1273-1280.
6. Sanchez-Moreno J., Martinez-Aran A., Tabares-Seisdedos R., et al. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 2009, 78:285-297.
7. Perlick D.A., Rosenheck R.A., Miklowitz D.J., et al. Prevalence and correlates of burden among caregivers of patients with bipolar disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder. Bipolar Disord 2007, 9:262-273.
8. Garlow S.J. Interventions for acute mood episodes in patients with bipolar disorder. J Clin Psychiatry 2008, 69:e05.
9. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002, 159(Suppl 4):1-50. American Psychiatric Association.
10. Yatham L.N., Kennedy S.H., Schaffer A., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009, 11:225-255.
11. Grunze H., Vieta E., Goodwin G.M., et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009, 10:85-116.
12. Goodwin G.M. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009, 23:346-388.
13. Yatham L.N., Paulsson B., Mullen J., Vagero A.M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004, 24:599-606.
14. Vieta E., Mullen J., Brecher M., et al. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin 2005, 21:923-934.
15. Bowden C.L., Grunze H., Mullen J., et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005, 66:111-121.
16. McIntyre R.S., Brecher M., Paulsson B., et al. Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005, 15:573-585.
17. Calabrese J.R., Keck P.E., Macfadden W., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005, 162:1351-1360.
18. Thase M.E., Macfadden W., Weisler R.H., et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006, 26:600-609.
19. Young A.H., McElroy S.L., Bauer M., et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010, 71:150-162.
20. McElroy S.L., Weisler R.H., Chang W., et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010, 71:163-174.
21. Figueroa C., Brecher M., Hamer-Maansson J.E., Winter H. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:199-204.
22. Velligan D.I., Weiden P.J., Sajatovic M., et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J Psychiatr Pract 2010, 16:306-324.
23. Suppes T., Datto C., Minkwitz M., et al. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 2010, 121:106-115.
24. Yildiz A., Vieta E., Leucht S., Baldessarini R.J. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology 2011, 36:375-389.
25. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
26. Spearing M.K., Post R.M., Leverich G.S., et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997, 73:159-171.
27. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
28. Simpson G.M., Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970, 212:11-19.
29. Barnes T.R. A rating scale for drug-induced akathisia. Br J Psychiatry 1989, 154:672-676.
30. Posner K., Oquendo M., Gould M., et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA's Pediatric Suicidal Risk Analysis of Antidepressants. Am J Psychiatry 2007, 164:1035-1043.
31. Vieta E., Ramey T., Keller D., et al. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. J Psychopharmacol 2010, 24:547-558.
32. Keck P.E., Orsulak P.J., Cutler A.J., et al. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord 2009, 112:36-49.
33. Keller M.B., Lavori P.W., Coryell W., et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986, 255:3138-3142.
34. Swann A.C., Bowden C.L., Morris D., et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997, 54:37-42.
35. Keck P.E., Versiani M., Warrington L., et al. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania. J Clin Psychiatry 2009, 70:844-851.
36. Tohen M., Chengappa K.N., Suppes T., et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002, 59:62-69.
37. Woods S.W., Money R., Baker C.B. Does the manic/mixed episode distinction in bipolar disorder patients run true over time?. Am J Psychiatry 2001, 158:1324-1326.
38. Keck P.E., Marcus R., Tourkodimitris S., et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003, 160:1651-1658.
39. Gonzalez-Pinto A., Aldama A., Pinto A.G., et al. Dimensions of mania: differences between mixed and pure episodes. Eur Psychiatry 2004, 19:307-310.
40. Calabrese J.R., Vieta E., El Mallakh R., et al. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry 2004, 56:957-963.
41. Vieta E., Bourin M., Sanchez R., et al. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry 2005, 187:235-242.
42. Tohen M., Ketter T.A., Zarate C.A., et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003, 160:1263-1271.
43. Young A.H., Oren D.A., Lowy A., et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry 2009, 194:40-48.
44. Khanna S., Vieta E., Lyons B., et al. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005, 187:229-234.
45. Tohen M., Goldberg J.F., Gonzalez-Pinto Arrillaga A.M., et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 2003, 60:1218-1226.